期刊文献+

不同方法对糖耐量减低干预效果的比较研究 被引量:3

The Comparative Study of Intervention Effect by Different Methods on the Population with Impaired Glucose Tolerance
下载PDF
导出
摘要 目的:比较不同干预方法对糖耐量减低的影响。方法:选取深圳市五个区IGT患者各100例,按照干预方案再分为对照组、饮食加运动组、阿卡波糖组、二甲双胍组和中药组各100例。分别于干预前后测定BMI、SBP、DBP、FPG、2hPG、HbA1C。结果:饮食运动组干预后FPG、2hPG与对照组干预后比较差异有统计学意义(P<0.05);阿卡波糖及二甲双胍组干预后FPG、2hPG、HbA1C均明显低于干预前、对照组、饮食运动组及中药组,其差异有统计学意义(P<0.05);中药组FPG、2hPG明显低于干预前及对照组,HbA1C低于对照组和饮食运动组,其差异有统计学意义(P<0.05)。结论:上述4种方法均有效降低血糖,尤以西药组突出。 Objective To evaluate the effect of different methods on the population with impaired glucose tolerance (IGT). Methods The total of five hundred IGT patients were divided into five groups according to interventions. BMI, SBP, the follow up. Results DBP, FPG, 2hPG, HbAIC were determined before intervention and yearly during By the end of the study, although the FPG and 2hPG slightly decreased in diet plus exercise group, they were significantly lower than those in the were significantly decreased in Acarbose and Metformin group. 2hPG were significantly lower than those of baseline and in control group. In contrast, the FPG, 2hPG and HbAIC In traditional Chinese medicine group, the FPG and control group, at the same time, the HbAIC were significantly lower than those in the control and diet plus exercise group. Conclusion These four methods can effectively lower blood sugar, especially the western medicine groups.
出处 《深圳中西医结合杂志》 2008年第3期145-147,共3页 Shenzhen Journal of Integrated Traditional Chinese and Western Medicine
基金 深圳市科技局项目(200404077)
关键词 糖耐量减低 生活方式 药物 干预研究 Impaired glucose tolerance Lifestyle Medicine Intervention
  • 相关文献

参考文献5

  • 1陆菊明,潘长玉,田慧,李春霖,杨国庆,张效良,李溪雅,成筱鹏,许志秀,蔡爱军,樊爱平,李永昌.二甲双胍和食物纤维在糖耐量低减人群向2型糖尿病发展中的干预作用[J].中国糖尿病杂志,2002,10(6):340-343. 被引量:44
  • 2Knowler WC, Barrett - Connor E, Fowler SE, et al. Diabetes Prevention program Research Group Reduction in the incidence of type-2 diabetes with lifestyle intervention or metformin [J]. N Engl J Med, 2002, 346:393-403.
  • 3杨文英,林丽香,齐今吾,于志清,裴海成,何国芬,杨兆军,王芃,李光伟,潘孝仁.阿卡波糖和二甲双胍对IGT人群糖尿病预防的效果——多中心3年前瞻性观察[J].中华内分泌代谢杂志,2001,17(3):131-134. 被引量:219
  • 4FA Van de Laar, PLBJ Lucassen, RP Akkermans, et al. Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose [J]. Cochrane Database Syst Rev, 2006, 18(4):CD005061.
  • 5Chiasson J-L, Josse RG, Gomis R, et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial [J]. Lancet, 2002, 359:2072-2077.

二级参考文献8

共引文献252

同被引文献48

引证文献3

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部